Leprosy Mailing List – May 10, 2022
Ref.: (LML) Infolep monthly overview of new publications on leprosy - May '22
From: Anniek Akerboom, Amsterdam, the Netherlands
Dear colleagues,
German Leprosy Relief Association (GLRA), one of Infolep's valued partners, launched a new Basic Course in Leprosy in Brazil. It is a free online course in Portuguese for health professionals, persons affected by leprosy and their families. The interactive modules contain short videos, making it a pleasurable learning experience. Learn more and start the course >>
The National Leprosy Programme of Côte d'Ivoire developed a Zero Leprosy Action Plan to reach leprosy targets by 2030. The plan was developed in partnership with the National Buruli Ulcer Control Programme, the Global Partnership for Zero Leprosy (GPZL), and local, national, and international partners working towards a Côte d'Ivoire free of skin neglected tropical diseases (NTDs) including leprosy. Learn more >>
Save the date! The NTD NGO Network (NNN) is pleased to announce that this year's NNN Annual Conference will take place from Tuesday 13th to Thursday 15th September 2022. The hybrid event will take place in Kathmandu, Nepal, and some elements will be streamed virtually.
The early-bird registration for the 21st International Leprosy Congress (ILC) has been extended until 15 May. Be sure to send in abstracts by 31 May. Learn more and register >>
Enjoy reading the latest publications on leprosy and have a look at the coming events below. Also, I would be happy to assist you with literature searches on Infolep.
Warm regards,
Anniek Akerboom
Infolep Coordinator
www.leprosy-information.org
a.akerboom@infolep.org
Highlighted
Curso Básico de Hansenîase
DAHW Brasil. 2022.
Zero leprosy: A united effort using existing & new tools but new perspectives
van Brakel W. Wolters Kluwer. Indian Journal of Medical Research. 2022.
Picturing health: the burden of leprosy in eastern Indonesia
Pieter Y, Grijsen ML. Elsevier BV. The Lancet. 2022; 399 (10335) : 1588-1599.
Leprosy & COVID-19
Impact of COVID-19 Disease on Health Care Services of Leprosy Patients Attending a Tertiary Care Centre, Telangana
Indira D, Damarla SV, Padmaja P, et al. Indian Journal of Leprosy. 2022.
Challenges Faced by People Affected with Leprosy During the COVID-19 Pandemic: A Questionnaire Based Study
Narang T, Mehta , Rathod S, et al. Indian Journal of Leprosy. 2022.
Leprosy Care in the Era of COVID - 19
Kahawita IP. Nepal Journals Online (JOL). Nepal Journal of Dermatology, Venereology & Leprology. 2022; 20 (1) : 4-11.
New publications
Feel free to contact me to receive full-text versions if these cannot be found through the Infolep portal.
Community perspectives on leprosy and related stigma in northern Nigeria: a qualitative study
Dahiru T, Iliyasu Z, Mande AT, et al. Lepra. Leprosy Review. 2022; 93 (1) : 48-62.
The Experiences of Leprosy Clients Attending Self-Care Groups During Community-Based Rehabilitation for Fulfilling Their Health Needs
Susanto T, Bahtiar S, Deviantony F, et al. Indian Journal of Leprosy. 2022.
Stigma and Self-concept of Leprosy Patients
Lufianti A, Mahanani S, Idris DNT. Scientific Foundation SPIROSKI. Open Access Macedonian Journal of Medical Sciences. 2022; 10 (G) : 300-305.
The end of leprosy is not imminent, but it is on the horizon.
Saunderson P, Duck M. The Indian journal of medical research. 2022.
Guiding policy towards zero leprosy: Challenges for modelling & economic evaluation
Blok D, De Vlas S J. Wolters Kluwer. Indian Journal of Medical Research. 2022.
Clinical profile of leprosy among domestic and migrant patients diagnosed at a tertiary referral centre in North Kerala: A ten-year retrospective data analysis.
George N, Majeed A, Sasidharanpillai S, et al. Indian journal of dermatology, venereology and leprology. 2022.
Spatial distribution pattern of new leprosy cases under 15 years of age and their contacts in Sobral, Ceará, Brazil
Linhares MSC, Kerr LRFS, Kendall C, et al. FapUNIFESP (SciELO). Ciência & Saúde Coletiva. 2022; 27 (4) : 1641-1652.
Processo de descoberta de conhecimento aplicados no desenvolvimento de uma plataforma de análise de dados sobre a hanseníase no município de Palmas
Perim da Cunha V. Federal University of Tocantins. 2022.
O papel do enfermeiro no controle da hanseníase na atenção básica
Santana JS, Silva RAN, Lima TOS, et al. Research, Society and Development. Research, Society and Development. 2022; 11 (4) : e51811427664.
Incapacidades físicas da hanseníase em menores de 15 anos no estado do Tocantins, Brasil, 2001 a 2020
Carvalho RA, Alencar JLG, Souza SMD, et al. Research, Society and Development. Research, Society and Development. 2022; 11 (5) : e18311527995.
Mycobacterium lepromatosis as Cause of Leprosy, Colombia.
Cardona-Castro N, Escobar-Builes M, Serrano-Coll H, et al. Emerging infectious diseases. 2022; 28 (5) : 1067-1068.
Nutritional Status of Patients With Leprosy Attending a Tertiary Care Institute in North India.
Jindal R, Nagrani P, Chauhan P, et al. Cureus. 2022; 14 (3) : e23217.
Serum level of Selenium, Zinc, and Vitamin C and their relation to the clinical spectrum of leprosy.
Khalid H, Mostafa M, Attia N, et al. Journal of infection in developing countries. 2022; 16 (3) : 491-499.
Reduced vitamin D receptor (VDR) and cathelicidin antimicrobial peptide (CAMP) gene expression contribute to the maintenance of inflammatory immune response in leprosy patients.
de Oliveira A, Chaves A, Cardoso M, et al. Microbes and infection. 2022.
Are the neglected tropical diseases under control in the tri-border region between Brazil, Argentina, and Paraguay?
Oliveira F, Arcêncio R, Arcoverde M, et al. Journal of infection in developing countries. 2022; 16 (3) : 547-556.
A Young Female With Borderline Lepromatous Leprosy and Tuberculous Lymphadenitis: A Rare Coinfection
Sami CA, Hassan SS, Khan AH, et al. Cureus, Inc.. Cureus. 2022.
Challenges related to the cases of lepromatous leprosy: a report of two cases.
Alfaragi M, Ahmed F, Osman W, et al. The Pan African medical journal. 2022.
Leprosy: clinical and immunopathological characteristics.
Froes L, Sotto M, Trindade M. Anais brasileiros de dermatologia. 2022.
Validity and reliability of the NEI VFQ-25 questionnaire in Indonesian leprosy patients
Rahayu T, Menaldi SL, Irawati Y, et al. Elsevier BV. Clinical Epidemiology and Global Health. 2022.
Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol.
Coleman M, Hill J, Timeon E, et al. BMJ open. 2022; 12 (4) : e055295.
Accuracy of rapid point-of-care serological tests for leprosy diagnosis: a systematic review and meta-analysis.
Romero C, Castro R, Brasil P, et al. Memorias do Instituto Oswaldo Cruz. 2022.
Editorial: The Role of Biomarkers in the Immunopathology and Diagnosis of Immune Exacerbations in Leprosy-New Frontiers to Manage This Neglected Disease.
Antas P, Santos D. Frontiers in medicine. 2022.
LepVax as a Promising Specific Vaccine for Leprosy: A Narrative Review
Adnan ML. Cambridge Medicine Journal. Cambridge Medicine Journal. 2022.
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.
Andrade E, Brandão J, da Silva J, et al. Antimicrobial agents and chemotherapy. 2022.
Drug resistance in leprosy: an update following 70 years of chemotherapy.
Aubry A, Rosa SP, Chauffour A, et al. Infectious diseases now. 2022.
Innovative drug delivery systems for leprosy treatment
da Rocha NP, Barbosa EJ, Barros de Araujo GL, et al. Scientific Scholar. Indian Journal of Dermatology, Venereology and Leprology. 2022.
Grade 2 disability among leprosy patients: A pilot study from an endemic area of Central India
Ganguly S, Shravani B, Shukla A, et al. Medknow. Journal of Family Medicine and Primary Care. 2022; 11 (4) : 1416.
Disease Disruption among People Affected by Leprosy
Govindharaj P, Srinivasan S, Darlong J. Indian Journal of Leprosy. 2022.
Ultrasonography as a diagnostic tool for Neural Pain in Leprosy.
Spitz C, Mogami R, Pitta I, et al. PLoS neglected tropical diseases. 2022; 16 (4) : e0010393.
Novel Recommendations to Enhance the Quality of Life in Patients with Neuropathy in Hansen's Disease
Abirami C, Kar HK. Indian Journal of Leprosy. 2022.
Analysis of therapeutic effectiveness and adverse effects of long-term corticosteroids among leprosy patients with reactions: A retrospective cohort study
Siagian JN, Purwantyastuti , Instiaty , et al. SAGE Publications. SAGE Open Medicine. 2022.
Leprosy Reactions and Neuropathic Pain in Pure Neural Leprosy in a Reference Center in Rio de Janeiro - Brazil.
Pitta I, Hacker M, Vital R, et al. Frontiers in medicine. 2022.
Epidemiological and clinical characterization of paraguayan patients with leprosy and household contacts before and after treatment with multi-drug therapy
Maiz GE, Rojas LE, Pereira JG, et al. Instituto de Investigaciones en Ciencias de la Salud. Anales de la Facultad de Ciencias Médicas (Asunción). 2022; 55 (1) : 49-62.
Epidemiological Determinants of Leprosy in a High Endemic District of India: A Community Based Case Control Study
Karotia D, Kishore J, Kumar A. Indian Journal of Leprosy. 2022.
Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis
Silva FJ, Santos-Garcia D, Zheng X, et al. American Society for Microbiology. Microbiology Spectrum. 2022.
In the footsteps of Albert Calmette: an ecological study of TB, leprosy and potential exposure to wild-type Mycobacterium bovis.
Pépin J, Fox A, LeBlanc L, et al. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2022
Events
NNN Conference
13-15 Sep 2022
Kathmandu & Virtual
COR-NTD Annual Meeting 2022
4 - 5 Oct | Virtual
21st International Leprosy Congress
>> Early-bird registration by 15 May
>> Abstract submission by 31 May
8-11 Nov 2022
Hyderabad & Virtual
Links
Info Hansen - A innovative hub for knowledge sharing about Hansen's Disease
ALLF - Official website of the Association des Léprologues de Langue Française
LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in leprosy to share ideas, information, experiences and questions
InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)
WHO Goodwill Ambassador's Leprosy Bulletin
Leprosy Review Repository (1928-2001)
Fontilles Revista de Leprología
GDPR & the Infolep newsletter
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our privacy statement and mailing list.
Infolep sends out monthly e-mails with an overview of recent publications on leprosy and related issues. The purpose of this activity is to keep subscribers up to date.
Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.
You can update your preferences or unsubscribe from this list at any time.
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
--You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/0d4f4c4b-d609-4cba-b90c-4d5ea40e0b98n%40googlegroups.com.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.